Apis Capital Advisors LLC decreased its holdings in shares of Celestica Inc. (NYSE:CLS - Free Report) TSE: CLS by 44.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 101,000 shares of the technology company's stock after selling 82,200 shares during the quarter. Celestica comprises approximately 6.2% of Apis Capital Advisors LLC's portfolio, making the stock its 6th biggest holding. Apis Capital Advisors LLC owned approximately 0.09% of Celestica worth $9,322,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in CLS. State Street Corp bought a new position in Celestica in the 3rd quarter valued at $452,000. Barclays PLC raised its position in shares of Celestica by 151.3% in the third quarter. Barclays PLC now owns 51,848 shares of the technology company's stock worth $2,651,000 after buying an additional 31,219 shares in the last quarter. Geode Capital Management LLC boosted its stake in Celestica by 8.6% during the third quarter. Geode Capital Management LLC now owns 109,915 shares of the technology company's stock valued at $6,236,000 after buying an additional 8,660 shares during the period. World Investment Advisors LLC purchased a new position in Celestica during the third quarter worth about $4,003,000. Finally, Franklin Resources Inc. increased its stake in Celestica by 21.1% in the 3rd quarter. Franklin Resources Inc. now owns 276,788 shares of the technology company's stock worth $14,149,000 after acquiring an additional 48,251 shares during the last quarter. Hedge funds and other institutional investors own 67.38% of the company's stock.
Insider Activity at Celestica
In related news, President Todd C. Cooper sold 65,000 shares of Celestica stock in a transaction on Friday, February 7th. The shares were sold at an average price of $129.78, for a total value of $8,435,700.00. Following the sale, the president now owns 110,426 shares in the company, valued at $14,331,086.28. The trade was a 37.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.00% of the stock is owned by company insiders.
Celestica Trading Up 1.5 %
Shares of NYSE CLS traded up $1.40 during midday trading on Wednesday, reaching $96.59. The company had a trading volume of 2,740,242 shares, compared to its average volume of 3,152,934. The firm's fifty day moving average price is $85.60 and its 200-day moving average price is $93.73. The company has a quick ratio of 0.87, a current ratio of 1.47 and a debt-to-equity ratio of 0.49. Celestica Inc. has a one year low of $40.25 and a one year high of $144.27. The stock has a market cap of $11.20 billion, a PE ratio of 25.83 and a beta of 1.65.
Celestica (NYSE:CLS - Get Free Report) TSE: CLS last released its quarterly earnings data on Thursday, April 24th. The technology company reported $1.20 earnings per share for the quarter, beating analysts' consensus estimates of $1.10 by $0.10. Celestica had a return on equity of 23.34% and a net margin of 4.61%. The firm had revenue of $2.65 billion during the quarter, compared to analyst estimates of $2.56 billion. During the same quarter in the prior year, the firm posted $0.83 earnings per share. The business's quarterly revenue was up 19.9% compared to the same quarter last year. On average, equities research analysts anticipate that Celestica Inc. will post 4.35 earnings per share for the current year.
Wall Street Analysts Forecast Growth
CLS has been the subject of several recent analyst reports. JPMorgan Chase & Co. boosted their price objective on Celestica from $105.00 to $115.00 and gave the stock an "overweight" rating in a report on Monday, April 28th. Argus cut their price target on shares of Celestica from $150.00 to $120.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. Barclays decreased their price target on shares of Celestica from $157.00 to $126.00 and set an "overweight" rating on the stock in a report on Monday, April 28th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $120.00 price objective on shares of Celestica in a report on Monday, April 28th. Finally, CIBC reduced their target price on Celestica from $150.00 to $120.00 and set an "outperformer" rating on the stock in a research note on Tuesday, April 15th. Two research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $105.42.
View Our Latest Research Report on CLS
About Celestica
(
Free Report)
Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.
Recommended Stories

Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.